Presight Capital

Investment Context

This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.

Presight Capital is a global venture fund tied to Christian Angermayer that backs companies from early to later stages, with public references to biotech, frontier technology, and cross-border expansion into the U.S., Europe, and selective other markets. In the psychedelic space, its relevance is strongest on the therapeutics side: it has been named in the financing syndicate for Delix Therapeutics and has been publicly associated with Compass Pathways, signaling sustained interest in psychedelic and psychedelic-adjacent drug development.